Skip to main content

Day: July 29, 2025

Vornado Realty Trust Leases 203,000 SF to Verizon for New York Headquarters in THE PENN DISTRICT

Telecommunications giant to relocate its New York headquarters to PENN 2NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE: VNO) today announced that Verizon, the iconic telecommunications firm, will relocate its New York headquarters to PENN 2, Vornado’s reimagined office tower in the heart of THE PENN DISTRICT campus. As part of a 19-year lease, Verizon will occupy nearly 200,000 square feet in office space across the eighth through tenth floors of PENN 2, which includes exclusive access to more than 25,000 square feet of outdoor space.  One of the world’s leading telecommunications firms and the largest mobile network operator in the United States, Verizon will also establish a flagship retail location on Seventh Avenue. “We are thrilled to welcome Verizon to the growing roster of world-renowned business,...

Continue reading

Responding to the White House AI Action Plan, ZenaTech’s ZenaDrone Launches Zena AI, Inc., a Specialized AI Development Center for US Defense and Homeland Security Applications

VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces the formation of Zena AI, Inc. (Zena AI), an AI Development Center part of its ZenaDrone US drone company subsidiary. Zena AI will be focused on building advanced artificial intelligence software solutions for the US Department of Defense and Homeland Security agencies. The announcement comes in response to the White House’s AI Action Plan and related Executive Orders released on July 23rd that set a nationwide agenda for accelerating American-made AI systems across federal and defense sectors and boosting...

Continue reading

Project Brownie, a 650 HP LT4 Powered Land Rover Built for a Sweet Tooth

KISSIMMEE, Fla., July 29, 2025 (GLOBE NEWSWIRE) — ECD Automotive Design (NASDAQ: ECDA), the industry leader in reimagined British classics and bespoke performance vehicles, proudly introduces its latest marvel: Project Brownie, a Land Rover Station Wagon transformed into an all-season daily driver with the soul of a supercar. View images of Project Brownie View video of Project Brownie Drenched in Nara Bronze Matte and fortified with a hand-built 6.2L GM LT4 Supercharged V8 delivering 650 horsepower, this custom Land Rover Station Wagon strikes a rare balance between timeless ruggedness and next-gen refinement. Designed for everything from snow-dusted mountain drives to coastal daily commutes, Project Brownie is as functional as it is fearsome. “Project Brownie is the kind of build that represents the evolution of the Land Rover....

Continue reading

Liberty Announces Closing of Listed Issuer Financing Exemption (LIFE) Private Placement of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR DISSEMINATION IN THE UNITED STATES WILMINGTON, Mass., July 29, 2025 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FRANKFURT: E30), a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, is pleased to announce that it has closed the non-brokered private placement of 20 million units (the “Units”) of the Company at the price of C$0.22 per Unit for gross proceeds of $4.4 million (the “Offering”), which was previously announced on July 8, 2025 and July 17, 2025. Each Unit will consist of one common share in the capital of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant will entitle the holder thereof to purchase one Common Share...

Continue reading

Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer’s Disease

– Zervimesine’s impact on debilitating DLB behavioral symptoms highlighted in podium presentation –– Plasma p-tau217 levels can identify Alzheimer’s patients most likely to benefit from zervimesine treatment –– Plasma and CSF biomarkers support zervimesine’s impact on Alzheimer’s disease biology – PURCHASE, N.Y., July 29, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, presented results from the Phase 2 COG1201 SHIMMER study (NCT05225415) of zervimesine (CT1812) in dementia with Lewy bodies (DLB) at the Alzheimer’s Association International Conference (AAIC 2025). As previously reported, the SHIMMER study met its primary endpoint of safety and tolerability. Results...

Continue reading

BriaCell’s Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

TILsRx platform designed to overcome immune suppression and T cell exhaustion to activate tumor-infiltrating lymphocytes (TILs) Multivalent technology enables simultaneous engagement of multiple cancer-associated and immune pathway targets A preferred tolerability profile is expected due to selective cancer cell targeting within the tumor microenvironment (TME) TILsRx platform early agents include antibodies to B7-H3, an immune checkpoint found in several cancers including prostate, lung, breast, pancreatic, and ovarianPHILADELPHIA and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, and its majority owned subsidiary, BriaPro Therapeutics...

Continue reading

Statement on recent news

Statement on recent news Turin, 29 July 2025. Iveco Group (EXM: IVG; the “Company”) communicates that it is engaged in ongoing, advanced discussions with different parties for potential transactions involving its defence business, on the one hand, and the balance of the Company on the other. In accordance with its fiduciary duties, the Board of Directors of the Company (the “Board”) is in the process of carefully reviewing and evaluating all aspects of these potential transactions. In doing so, the Board is giving careful consideration to the interests of Iveco Group and all its stakeholders, including its shareholders, employees and clients. The Board will keep the market updated in accordance with applicable laws. Iveco Group N.V. (EXM: IVG) is the home of unique people and brands that power your business and mission to advance a more...

Continue reading

Lassonde Industries Inc. announces departure of Eric Gemme, Chief Financial Officer, in July 2026

ROUGEMONT, Quebec, July 29, 2025 (GLOBE NEWSWIRE) — Lassonde Industries Inc. (TSX: LAS.A) (“Lassonde” or the “Corporation”) today announced that after consideration of his personal and professional goals, Eric Gemme, its Chief Financial Officer, will be retiring from Lassonde on July 1, 2026. The timing of the departure enables a thoughtfully managed transition for the Corporation. “Eric has been a trusted colleague who has supported me and the leadership team in the implementation of a new strategy for Lassonde. As well, through his leadership and dedication, he has strengthened our financial capabilities, enabled key acquisitions, and fostered important stakeholder relations. On behalf of our Board and management team, I wish him all the best in his future endeavors, said Vince Timpano, Chief Executive Officer of Lassonde.” “I...

Continue reading

Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk

Bagsværd, Denmark, 29 July 2025 – Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds Lars Fruergaard Jørgensen, who will step down as president and chief executive officer on the same date. The company also announced other executive-level changes, effective 7 August. Mike Doustdar, currently Novo Nordisk’s executive vice president of International Operations, has a strong track record of creating value and driving growth. Under his leadership over the past decade, Novo Nordisk’s International Operations have more than doubled sales to approximately DKK 112 billion in 2024. The business includes all of Novo Nordisk’s affiliates outside of the US and employs nearly 20,000 people. Novo Nordisk Chair, Helge Lund, said: “Mike is...

Continue reading

ZOOZ Announces Private Placement of $180 Million to Launch a Bitcoin Treasury Reserve Strategy

ZOOZ to become the first Nasdaq and TASE dual-listed company to hold Bitcoin in its treasury The Board of Directors of the Company has approved the new strategy, which provides investors with exposure to Bitcoin Jordan Fried to become CEO to lead the first Israeli digital asset treasury strategy Largest offering by a Non-US Listed Company to launch a digital asset treasury strategy TEL AVIV, Israel, July 29, 2025 (GLOBE NEWSWIRE) — ZOOZ Power Ltd. (Nasdaq and TASE: ZOOZ) (“ZOOZ” or the “Company”) today announced a $180 million private placement, or PIPE, with accredited institutional investors in connection with its plans to launch a Bitcoin Reserve Strategy. The PIPE, which is subject to shareholders’ approval, is expected to involve the sale of 180 million of the Company’s ordinary shares and pre-funded warrants at a purchase...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.